Loading provider…
Loading provider…
Hematology & Oncology Physician in Cumming, GA
NPI: 1205875218HQ Phone
Get MD Ronald's Phone Numberphone_androidMobile
Get MD Ronald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation.
Authors: Sami Diab, Cynthia Ma, Joyce O'Shaughnessy, Paul Richards
Publication Date: 2018-03-20
Authors: Tina Maluso, Jose Lutzky, Youram Nassir, Jacob Bitran, Shahrooz Eshaghian, James Berenson, James Wang, Laura Stampleman, Sikander Ailawadhi, Mehdi Moezi
Journal: Support Care Cancer
Publication Date: 2017-04-28
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, PROCEDURE: Multigated Acquisition Scan, BIOLOGICAL: Sargramostim, PROCEDURE: Echocardiography Test, PROCEDURE: Magnetic Resonance Elastography
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: Multigated Acquisition Scan, DRUG: Trametinib Dimethyl Sulfoxide, PROCEDURE: Echocardiography Test, DRUG: Dabrafenib Mesylate
Lead Sponsor: Elios Therapeutics, LLC
Collaborators: LumaBridge
Intervention / Treatment: DRUG: Placebo, DRUG: TLPLDC